Related Experiment Video
Updated: Aug 24, 2025

10:38
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
23.2K
Accelerated development of malaria monoclonal antibodies
Narimane Nekkab1, Melissa A Penny1
1Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.
Cell Reports. Medicine
|October 19, 2022
Abstract:
L9LS, a potent and safe antimalarial monoclonal antibody, demonstrated 88% protective efficacy against infection in a phase 1 trial in healthy adults.1 These promising results are the first of many to usher in a potential new era of malaria prevention.

